AnalyzeDirect

Tag Archives: Pyrimidines/pharmacology

p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment

Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, Willette RN, Jucker BM. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol. February 2008;28(2):265-271. Full Text – Open Access Publication Date February 2008 How Analyze was Used “All images…

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging

Lenhard SC, Nerurkar SS, Schaeffer TR, Mirabile RC, Boyce RW, Adams DF, Jucker BM, Willette RN. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging. J Pharmacol Exp Ther. December 2003;307(3):939-946. Full Text – Open Access Publication Date December 2003 How Analyze…

SPECT imaging with the D4 receptor antagonist L-750,667 in nonhuman primate brain

Staley JK, Tamagnan G, Baldwin RM, Fujita M, Al Tikriti MS, Eshima L, Thornback J, Roe D, Lu L, Seibyl JP, Innis RB. SPECT imaging with the D4 receptor antagonist L-750,667 in nonhuman primate brain. Nucl Med Biol. August 2000;27(6):547-556. Publication Date August 2000 How Analyze was Used “The skull was stripped from the MRI…